- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00316108
Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH) (BEACH)
Boston Scientific EPI: A Carotid Stenting Trial for High-Risk Surgical Patients
Study Overview
Status
Intervention / Treatment
Detailed Description
Stroke is the third leading cause of death in this country with approximately 600,000 new stroke cases each year. Mortality rates as high as 40 percent have been reported for stroke as a result of ischemia associated with the carotid distribution. Currently, the primary therapy for carotid artery occlusive disease is carotid endarterectomy (CEA) or the surgical removal of atheromatous material from inside the artery.
Although CEA is an effective treatment for the majority of patients with carotid occlusive disease, there remains a need for a treatment option for those patients with significant surgical risk factors. These patients have been shown to have much higher rates of morbidity and mortality. There are approximately 50,000-70,000 patients each year who are considered poor surgical candidates. These patients present with either one or more anatomical or co-morbid conditions and have a one-year stroke and death rate of up to 15% with traditional surgical treatment.
Carotid artery stenting (CAS) has been reported by numerous single-center trials to be feasible in the treatment of carotid artery stenosis. Moreover, the risk benefit ratio has been suggested to be the largest in those patients with a higher risk profile for the CEA treatment option.
This trial will study the effects of percutaneous intervention using the Monorail™ Carotid Wallstent® Endoprosthesis (Carotid Wallstent) in conjunction with the FilterWire System distal protection device (FilterWire EX and EZ) on rates of common peri-procedural complications as well as on long-term outcomes as compared to historical outcomes of patients undergoing CEA.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
Birmingham, Alabama, United States, 35211
- Bapatist Medical Center
-
-
Arizona
-
Phoenix, Arizona, United States, 85006
- Arizona Heart Institute
-
Phoenix, Arizona, United States, 85013
- St. Joseph's Hospital & Medical Center
-
-
California
-
Mountain View, California, United States, 94040
- El Camino Hospital
-
Newport Beach, California, United States, 92658
- Hoag Memorial Hospital
-
Stockton, California, United States, 95204
- St. Joseph's Medical Center
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Washington Hospital Center
-
-
Florida
-
Ft. Lauderdale, Florida, United States, 33308
- Holy Cross Hospital
-
Lakeland, Florida, United States, 33805
- Lakeland Regional Medical Center
-
Miami, Florida, United States, 33101
- University of Miami School of Medicine - Jackson Memorial Hospital
-
Miami, Florida, United States, 33176
- Miami Cardiac and Vascular Institute
-
Plantation, Florida, United States, 33324
- Northwest Medical Center
-
-
Georgia
-
Atlanta, Georgia, United States, 30309
- Piedmont Hospital
-
Atlanta, Georgia, United States, 30342
- St. Joseph's Hospital of Atlanta/American Cardiovascular Research Institute
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Rush Presbyterian-St. Luke's Medical Center
-
Peoria, Illinois, United States, 61637
- St. Francis Medical Center
-
Springfield, Illinois, United States, 62701
- St. John's Hospital - Prairie Heart Institute
-
-
Kentucky
-
Lexington, Kentucky, United States, 40504
- Central Baptist Hospital
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70121
- Ochsner Clinic Foundation
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
Hyannis, Massachusetts, United States, 02601
- Cape Cod Hospital
-
-
Michigan
-
Detroit, Michigan, United States, 48034
- Wayne State University- Detroit Medical Center
-
Royal Oak, Michigan, United States, 48073
- William Beaumont Hospital
-
-
Missouri
-
Kansas City, Missouri, United States, 64111
- St. Luke's Hospital of Kansas City
-
-
New York
-
Bronx, New York, United States, 10467
- Montefiore Medical Center
-
Buffalo, New York, United States, 14209
- Kaleida Health/Millard Fillmore Hospital
-
New York, New York, United States, 10021
- Lenox Hill Heart and Vascular Institute
-
New York, New York, United States, 10032
- New York Presbyterian Hospital/Columbia Vascular Interventional Radiology
-
Rochester, New York, United States, 14603
- Strong Memorial Hospital
-
Roslyn, New York, United States, 11576
- St. Francis Hospital
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic & Foundation
-
Columbus, Ohio, United States, 43202
- Riverside Methodist Hospital
-
Toledo, Ohio, United States, 43614
- Medical College of Ohio
-
-
Oregon
-
Portland, Oregon, United States, 97201
- Oregon Health Sciences University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19102
- Hahnemann University/ Tenet Healthcare Corporation
-
Pittsburgh, Pennsylvania, United States, 15232
- UPMC-Shadyside Hospital Pittsburgh Vascular Institute
-
Wormleysburg, Pennsylvania, United States, 17101
- Pinnacle Health at Harrisburg Hospital
-
-
South Carolina
-
Columbia, South Carolina, United States, 29204
- Providence Hospital South Carolina Heart Center
-
-
Tennessee
-
Knoxville, Tennessee, United States, 37920
- Baptist Hospital of East Tennessee
-
Nashville, Tennessee, United States, 37207
- Skyline Medical Center/ Howell Allen Clinic
-
-
Texas
-
Houston, Texas, United States, 77030
- St. Luke's Episcopal Hospital Texas Heart Institute
-
Houston, Texas, United States, 77030
- University of Texas-Houston Medical School
-
Lubbock, Texas, United States, 79430
- Texas Tech University Health Sciences Center
-
San Antonio, Texas, United States, 78201
- Baptist Hospital
-
-
Utah
-
Salt Lake City, Utah, United States, 84143
- LDS Hospital
-
-
Virginia
-
Richmond, Virginia, United States, 23226
- St. Mary's Hospital
-
-
Washington
-
Spokane, Washington, United States, 99204
- Deaconess Medical Center
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53215
- Aurora St. Luke's Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Key General Inclusion Criteria:
- Patient must meet criteria for either A or B:
A. Symptomatic: Carotid stenosis of greater than or equal to 50% via angiography with associated cerebral or retinal TIA or ischemic stroke symptoms within 180 days of the procedure, which are determined to have occurred in the cerebral hemisphere or eye ipsilateral to the target carotid artery lesion and to be reasonably attributable to that lesion; or
B. Asymptomatic: Carotid stenosis greater than or equal to 80% via angiography without associated cerebral or retinal TIA or ischemic stroke symptoms within 180 days of the procedure.
- Target lesion is in the native common carotid artery (CCA), internal carotid artery (ICA), or carotid bifurcation.
- Target arterial segment to be stented has a diameter of greater than or equal to 4.0 mm to less than or equal to 9.0 mm.
- Vessel diameter distal to the target lesion is greater than or equal to 3.5 mm and less than or equal to 5.5 mm as an optimal "landing zone" for placement of the FilterWire EZ System with visual angiographic recommendations as described in the instructions for use (IFU).
Key High-Risk Eligibility Inclusion Criteria:
Patients must qualify in at least one high-risk category. The high-risk categories are defined as:
- Anatomical conditions [one (1) criterion qualifies]
- Co-morbid conditions Class I [one (1) criterion qualifies]
- Co-morbid conditions Class II [two (2) criteria qualify]
Exclusion Criteria:
- Patient has experienced an evolving, acute, or recent stroke within 21 days of study evaluation.
- A total occlusion of the ipsilateral carotid artery. (Only for Roll-In and Pivotal patients.)
- A total occlusion of the contralateral carotid artery. (Only for Bilateral Registry patients.)
Pre-existing stent(s):
- Roll-In and Pivotal Patients: located within the ipsilateral carotid distribution; a stent was placed in a contralateral vessel within the previous 30 days of the study enrollment.
- Bilateral Registry Patients: located within the carotid distribution.
- A target lesion which is expected to require more than one stent.
- Known cardiac sources of emboli of a type likely to be associated with cerebral ischemic events [e.g. endocarditis, intracardiac thrombus, embolic-associated cardiovascular lesions, or any current arrhythmia (e.g. atrial fibrillation, atrial flutter, etc.)].
- Myocardial infarction (MI) within 72 hours prior to the index procedure, defined as creatine kinase (CK)-MB > 2 X the local laboratory's upper limit of normal (ULN).
- Any surgery requiring general anesthesia (e.g. coronary artery bypass graft [CABG], valve replacement, or abdominal aortic aneurysm) less than or equal to 30 days preceding the stent procedure.
- The patient is enrolled in another investigational study protocol and has not completed the required follow-up period of the evaluation. The patient may not participate in another investigational study that may confound the treatment or outcomes of the BEACH protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm 1
|
Carotid Artery Stent
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary endpoint is one-year morbidity and mortality, defined as the cumulative incidence of any non Q-wave myocardial infarction within the 24 hours following carotid stenting
Time Frame: 1 year
|
1 year
|
peri-procedural (within 30 days of procedure) death, stroke, Q-wave myocardial infarction
Time Frame: Within 30 days of Procedure
|
Within 30 days of Procedure
|
late ipsilateral stroke or death due to neurologic events from 31 days up to and including twelve-month follow-up.
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Peri-procedural morbidity and mortality
Time Frame: Within 30 Days of procedure
|
Within 30 Days of procedure
|
FilterWire EX and EZ System technical success
Time Frame: Post procedure
|
Post procedure
|
Carotid Wallstent technical success
Time Frame: Post Procedure
|
Post Procedure
|
system technical success
Time Frame: Post Procedure
|
Post Procedure
|
angiographic success
Time Frame: Post Procedure
|
Post Procedure
|
procedural success
Time Frame: Post Procedure
|
Post Procedure
|
30-day clinical success
Time Frame: 30 days post procedure
|
30 days post procedure
|
peri-procedural overall morbidity
Time Frame: 30 days post procedure
|
30 days post procedure
|
one-year clinical success
Time Frame: 1 Year post procedure
|
1 Year post procedure
|
late stroke, transient ischemic attack (TIA) and death.
Time Frame: 1 year post procedure
|
1 year post procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christopher White, MD, Ochsner Health System
- Principal Investigator: Sriram Iyer, MD, Lenox Hill Heart and Vascular Institute
- Study Director: Pamela G Grady, Ph.D, Boston Scientific Corporation
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S5385
- COR2000001U
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on WALLSTENT® Endoprosthesis™
-
Boston Scientific CorporationCompletedCarotid Artery DiseaseUnited States
-
Centro Cardiologico MonzinoUnknown
-
Pamela Youde Nethersole Eastern HospitalCompletedColonic NeoplasmsHong Kong
-
Stockholm South General HospitalCompletedPancreatic Neoplasms | Biliary Tract Neoplasms | Stent OcclusionSweden
-
W.L.Gore & AssociatesSuspendedPancreatitis, Chronic | Stricture; Bile DuctUnited States
-
W.L.Gore & AssociatesCompletedAortic Aneurysm, AbdominalUnited States
-
W.L.Gore & AssociatesCompletedAortic Aneurysm, ThoracicUnited States
-
W.L.Gore & AssociatesCompletedIatrogenic Vessel Injury
-
W.L.Gore & AssociatesCompleted
-
W.L.Gore & AssociatesCompletedPeripheral Arterial DiseaseJapan